Jeffrey Humphrey

Business address
C/O Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, MA, 02142
Top holdings (ownership)
LNTH
Get insider transactions for this reporting owner
Jeffrey Humphrey has filed 15 SEC EDGAR filings since 08 Jul 2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 20 Jun 2024 17 Jun 2024 001-36569
3 Open Document Open Filing 3 06 Jun 2024 28 May 2024 001-36569
4 Open Document Open Filing FORM 4 SUBMISSION 07 Feb 2023 03 Feb 2023 001-40499
4 Open Document Open Filing FORM 4 SUBMISSION 01 Aug 2022 01 Aug 2022 001-38541
4 Open Document Open Filing FORM 4 SUBMISSION 19 May 2022 17 May 2022 001-38541
4 Open Document Open Filing FORM 4 SUBMISSION 24 Feb 2022 22 Feb 2022 001-40499
4 Open Document Open Filing FORM 4 SUBMISSION 17 Feb 2022 15 Feb 2022 001-38541
4 Open Document Open Filing FORM 4 SUBMISSION 16 Dec 2021 15 Dec 2021 001-40499
3 Open Document Open Filing FORM 3 SUBMISSION 16 Dec 2021 15 Dec 2021 001-40499
4 Open Document Open Filing FORM 4 SUBMISSION 04 Oct 2021 01 Oct 2021 001-38541
3 Open Document Open Filing FORM 3 SUBMISSION 04 Oct 2021 01 Oct 2021 001-38541
4 Open Document Open Filing PRIMARY DOCUMENT 19 Jul 2021 15 Jul 2021 001-38584
4 Open Document Open Filing PRIMARY DOCUMENT 18 Feb 2021 16 Feb 2021 001-38584
4 Open Document Open Filing PRIMARY DOCUMENT 08 Jul 2020 07 Jul 2020 001-38584
3 Open Document Open Filing PRIMARY DOCUMENT 08 Jul 2020 22 Jun 2020 001-38584